Paydirt
MH
Insider

Michael Thomas Heffernan

Director

Michael Thomas Heffernan (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Trevi Therapeutics, Inc. (TRVI). The largest single filing was $593K of TRVI (39,273 sh across 2 lots, as filed), executed Sep 15.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$593K
shares × price, as filed
Last traded
Sep 15
Filed Sep 17

Median ADV $33.1M across their filed names

Open performance→
Volume by month
$593K$296K$0Oct 2024Apr 2025Oct 2025Apr 2026Sep 2026 · sells $593K
Buys $0 Sells $593K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
TRVI Trevi Therapeutics, Inc. TRVI · 0 buys · 1 sell 1 filing
Recent filings
TRVISALE Trevi Therapeutics, Inc. View filing → $593K
39,273 sh across 2 lots
Exec Sep 15
Filed Sep 17 · 4:55 PM ET